Kyle Michael Wool Buys $150K of AIkido Pharma Inc (AIKI) — SEC Form 4, Sep 15, 2022

Open-Market Net Purchase · SEC Form 4

+$149,931

Equity position changed by +20.4%

Reporting Owner

Kyle Michael Wool

Director

TXN 2022-09-13 · FILED 2022-09-15

Equity Position 140K sh 116,356 → 140,068

Equity Change +20.4% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

AIkido Pharma Inc

AIKI CIK 0000012239

Reporting Owner

Name	Relationship
Kyle Michael Wool CIK 0001856536	Director

Kyle Michael Wool at AIkido Pharma Inc Full insider history

Bought (12 mo) $209,190

Sold (12 mo) $96,798

More from this insider at AIkido Pharma Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common Stock	2022-09-13	P - Purchase	23,712 A	$6.32	+$149,931	140,068	Direct

Remarks

On September 13, 2022, the reporting person purchased 23,712 shares of common stock in the public market at $6.323 per share.

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 4 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at AIkido Pharma Inc

GET /v1/forms/4/0001213900-22-056071 API docs